EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+8.73%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.22B
AUM Growth
+$1.22B
(+47%)
Cap. Flow
+$338M
Cap. Flow
% of AUM
27.68%
Top 10 Holdings %
Top 10 Hldgs %
49.95%
Holding
96
New
33
Increased
24
Reduced
16
Closed
17
Top Buys
| 1 |
ARK Genomic Revolution ETF
ARKG
|
$71.6M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$32.8M |
| 3 |
Community Health Systems
CYH
|
$32.4M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$26.5M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$24.1M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$23.6M |
| 2 |
The Ensign Group
ENSG
|
$16.9M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$12.3M |
| 4 |
HSKA
Heska Corp
HSKA
|
$11M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
$9.78M |
Sector Composition
| 1 | Healthcare | 92.79% |
| 2 | Consumer Discretionary | 0.09% |
| 3 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Surmodics
SRDX
$487M
| $2.69M | 0.2% |
47,906
+6,607
| +16% | +$370K |
|
52
Humacyte
HUMA
$231M
| $2.59M | 0.19% |
+239,026
| New | +$2.59M |
|
53
Lexicon Pharmaceuticals
LXRX
$392M
| $2.41M | 0.18% |
+410,593
| New | +$2.41M |
|
54
Agilent Technologies
A
$35.5B
| $1.94M | 0.15% |
15,261
+10,284
| +207% | +$1.31M |
|
55
Intuitive Surgical
ISRG
$158B
| $1.91M | 0.14% |
+2,583
| New | +$1.91M |
|
|
HSKA
56
DELISTED
Heska Corp
HSKA
| $1.86M | 0.14% |
11,040
-65,126
| -86% | -$11M |
|
57
Exagen
XGN
$213M
| $1.83M | 0.14% |
104,437
+22,834
| +28% | +$400K |
|
58
Prothena Corp
PRTA
$452M
| $1.72M | 0.13% |
68,575
-134,753
| -66% | -$3.38M |
|
59
Keros Therapeutics
KROS
$640M
| $1.7M | 0.13% |
+27,631
| New | +$1.7M |
|
|
XENT
60
DELISTED
Intersect ENT, Inc
XENT
| $1.57M | 0.12% |
+75,389
| New | +$1.57M |
|
|
TLGT
61
DELISTED
Teligent, Inc
TLGT
| $1.56M | 0.12% |
+2,500,260
| New | +$1.56M |
|
|
CFMS
62
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.53M | 0.11% |
+1,541,978
| New | +$1.53M |
|
63
Liquidia Corp
LQDA
$2.52B
| $1.35M | 0.1% |
+500,010
| New | +$1.35M |
|
64
IQVIA
IQV
$31.4B
| $1.14M | 0.09% |
5,921
+1,836
| +45% | +$355K |
|
65
Chewy
CHWY
$16.8B
| $1.11M | 0.08% |
+13,100
| New | +$1.11M |
|
|
RAD
66
DELISTED
Rite Aid Corporation
RAD
| $1.11M | 0.08% |
54,025
-477,979
| -90% | -$9.78M |
|
67
InflaRx
IFRX
$117M
| $1.05M | 0.08% |
+268,634
| New | +$1.05M |
|
68
Cabaletta Bio
CABA
$144M
| $853K | 0.06% |
+76,849
| New | +$853K |
|
69
GoHealth
GOCO
$77.4M
| $805K | 0.06% |
68,899
+39,214
| +132% | +$458K |
|
|
IMMP
70
Immutep
IMMP
$237M
| $767K | 0.06% |
+249,895
| New | +$767K |
|
71
Apellis Pharmaceuticals
APLS
$3.51B
| $554K | 0.04% |
12,900
+9,084
| +238% | +$390K |
|
72
QuidelOrtho
QDEL
$1.87B
| $529K | 0.04% |
4,132
-36,451
| -90% | -$4.66M |
|
|
APTO
73
DELISTED
Aptose Biosciences, Inc.
APTO
| $478K | 0.04% |
+80,000
| New | +$478K |
|
74
Repligen
RGEN
$6.54B
| $278K | 0.02% |
+1,428
| New | +$278K |
|
|
OXFD
75
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| – | – |
-307,742
| Closed | -$5.37M |
|